Viral infection triggers host innate immune responses that result in the production of various cytokines including type I interferons (IFN), activation of inflammasomes, and programmed cell death of the infected cells. Tight control of inflammatory cytokine production is crucial for the triggering of an effective immune response that can resolve the infection without causing host pathology. In examining the inflammatory response of Asc À/À and Casp1 À/À macrophages, we found that deficiency in these molecules resulted in increased IFN production upon DNA virus infection, but not RNA virus challenge. Investigation of the underlying mechanism revealed that upon canonical and non-canonical inflammasome activation, caspase-1 interacted with cyclic GMP-AMP (cGAMP) synthase (cGAS), cleaving it and dampening cGAS-STING-mediated IFN production. Deficiency in inflammasome signaling enhanced host resistance to DNA virus in vitro and in vivo, and this regulatory role extended to other inflammatory caspases. Thus, inflammasome activation dampens cGAS-dependent signaling, suggesting cross-regulation between intracellular DNA-sensing pathways.
In Brief
Type I interferons (IFN) can inhibit inflammasome activation. Wang et al. find that upon inflammasome activation, inflammatory caspases cleave cGAS and render it inactive. Their findings reveal a role for inflammasomes in the dampening of IFN activating pathways and suggest a double-negative feedback loop that regulates the output of DNA-sensing pathways.
INTRODUCTION

Viral infection triggers host antiviral innate immune responses.
Cells use different pattern-recognition receptors to detect viral infection by sensing viral nucleic acids (Takeuchi and Akira, 2010) . Whereas Toll-like receptor 3 (TLR3) recognizes viral double-stranded RNA (dsRNA) and triggers downstream pathway by TRIF (TIR domain-containing adaptor inducing interferon-b) (Alexopoulou et al., 2001) , retinoic acid-inducible gene I (RIG-I)-like helicases (Yoneyama et al., 2004) recognize cytoplasmic viral RNAs, and are transduced by the mitochondrial protein MAVS (VISA, IPS-1, or Cardif) (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) . For cytoplasmic DNA sensing, it has been discovered that cGAS (cyclic GMP-AMP (cGAMP) synthase) (Sun et al., 2013) recognizes cytosolic DNA and produces cGAMP Civril et al., 2013; Gao et al., 2013; Wu et al., 2013a) , which functions as a second messenger to activate STING (stimulator of IFN genes, also named MITA or ERIS) (Ishikawa and Barber, 2008; Sun et al., 2009; Zhong et al., 2008) . Additionally, RNA polymerase III Chiu et al., 2009 ) serves as another cytoplasmic sensor of DNA by transcribing AT-rich dsDNA into dsRNA, thus stimulating RIG-I-MAVS pathway. Activation of these receptors leads to the activation of transcription factors NF-kB and IFN regulatory factor IRF-3 or IRF-7 and the production of various cytokines including type I-IFNs. Secreted type I-IFNs bind to their receptor and induce the expression of hundreds of interferon-stimulated genes (ISGs), which interfere with almost every step of viral replication, resulting in the establishment of a cellular anti-viral state (Takeuchi and Akira, 2010) .
Microbial infection also causes pathological inflammation, which is mediated by the activation of inflammasome complexes, leading to the activation of inflammatory caspases (caspase-1, and caspase-4/5 in human, or caspase-11 in mouse) (Kumar, 2007; McIlwain et al., 2015) . Inflammasomes are triggered by Nod-like receptors (NLRs), which recognize microbial products, including viral nucleic acids, or endogenous molecules released from damaged or dying cells (Kanneganti, 2010; Rathinam et al., 2012) . Upon activation, NLRs oligomerize and recruit pro-caspase-1, with or without the help of ASC (apoptosis-associated speck-like protein with a caspase-recruitment domain), leading to the activation of caspase-1, and subsequent proteolytic conversion of proinflammatory cytokines, interleukin-1 (IL1b) and IL-18 from their precursors (Rathinam et al., 2012) . AIM2 (absent in melanoma 2) has also been shown to activate ASC-dependent inflammasome in response to cytosolic dsDNA (Fernandes-Alnemri et al., 2009; Hornung et al., 2009 ). Additionally, either caspase-1 or caspase-11 triggers a form of lytic, programmed cell death called pyroptosis (Jorgensen and Miao, 2015) . Interestingly, caspase-1 has been shown to cleave proteins involved in innate immune activation, such as Mal and TRIF, resulting in reduced cytokine production after bacterial infections because both play essential roles in TLR-mediated signaling (Jabir et al., 2014; Miggin et al., 2007; Ulrichts et al., 2010) .
Although type I-IFNs are critical for suppressing the spread of viral infection, aberrant production of these cytokines can have pathological roles in a variety of autoimmune disorders (Crow, 2014; Ivashkiv and Donlin, 2014; Nallar and Kalvakolanu, 2014) . Importantly, because microbial infection usually leads to type I-IFN production and inflammasome activation, balance between these key pathways is essential for immune homeostasis. Indeed, it has been reported that rheumatic diseases, for example, is either driven by inflammasome-induced proinflammatory secretion or by abnormal type I-IFN production (van Kempen et al., 2015) . Previous work demonstrated that type I-IFNs inhibit inflammasome activation (Guarda et al., 2011) and that various NLRs such as NLRX1 (Lei et al., 2012; Moore et al., 2008) , NLRP4 (Cui et al., 2012) , NLRP6 (Anand et al., 2012) , NLRC3 (Schneider et al., 2012; Zhang et al., 2014) , and NLRC5 (Benko et al., 2010; Cui et al., 2010) negatively regulate type I-IFN induction in different ways, highlighting the importance of this fine-tuning regulation.
Here we report that caspases controlled antiviral immunity through cGAS cleavage during inflammasome activation. Upon inflammasome activation, caspase-1 directly bound to and cleaved human cGAS at D 140/157 , resulting in reduced cGAMP production and cytokine expression. Consequently, caspase-1, AIM2-and ASC-deficient mice showed enhanced resistance to infection by DNA but not RNA virus. cGAS was also cleaved by caspase-4, -5, and -11 during non-canonical inflammasome activation, triggered by intracellular lipopolysaccharides (LPS) delivery. Importantly, we also found that cGAS N-terminal R/K-rich region between residues 122 to 133 of human cGAS and residues 119 to 132 of mouse cGAS was critical for its normal function. Our study therefore revealed a role for caspases in the regulation of cGAS-STING pathway and provided molecular insight into the coordination between antiviral innate immune and inflammasome activation. Because numerous caspase inhibitors are under clinical trials, our findings suggested that these inhibitors' potential effect as immune boosters should be closely investigated and efforts should be made to avoid unwanted or excessive innate immune activation caused by these inhibitors.
RESULTS
Asc
-/-or Casp1 -/-Deficiency Augments Cytokine Production and Host Resistance to DNA Virus Infection In our screening of molecules that regulate virus-triggered innate immune activation, we detected higher type I-IFN, interleukin-6 (IL-6) and TNF production in peritoneal macrophages from either Asc À/À or Casp1 À/À mice than in those from wild-type mice. This increase was observed in response to genomic DNA (gDNA) transfection, as well as DNA virus herpes simplex virus 1 (HSV-1) or Vaccinia virus (VACV) infection, but not to infection by Sendai virus (SeV), an RNA virus (Figures 1A and 1B and S1A) . Consistently, the mRNA levels of Ifna, Ifnb, , and some ISGs were significantly higher in Asc À/À and Casp1 À/À macrophages transfected with gDNA ( Figure S1B) . Similarly, the activation of the kinase TBK1 represented by its phosphorylation and the production of Viperin, a well-known ISG (Chin and Cresswell, 2001) , were enriched in these deficient cells ( Figure 1C ). Fluorescent microscopy and flow cytometry analysis showed that compared to WT cells, Asc À/À and Casp1 À/À cells were resistant to HSV-1-GFP infection, whereas all these cells showed similar susceptibility to another RNA virus vesicular stomatitis virus (VSV)-GFP infection ( Figures  S1C and S1D ). These data suggested that ASC and caspase-1 negatively regulate cytosolic DNA, but not RNA triggered innate immune responses in mouse cells.
To confirm this observation in human cells, we performed RNAi of caspase-1 in human acute monocytic leukemia cell line THP-1 by shRNA and studied type I-IFN induction upon viral infection (Lei et al., 2013) . When infected with VACV or HSV-1, we could detect visible increases in IRF3 activation and Viperin expression after caspase-1 expression was interfered (CASP1 RNAi ), which were not observed in SeV-infected cells (Figure 1D) . Consistently, type I-IFNs were boosted in CASP1
RNAi cells by HSV-1 or VACV, but not SeV infection ( Figure 1E ). As a well-known ISG and a critical transcription factor for type I-IFN production, the induction and dimerization of IRF-7 were all stronger in CASP1 RNAi cells in response to DNA virus (Figure S1E) . AIM2 was shown to activate ASC-dependent inflammasome in response to cytosolic dsDNA. We observed similar results as macrophages from Aim2 À/À mice showed exaggerated responses only to DNA virus (Figures 1F and 1G) , which is consistent with previous results (Corrales et al., 2016; Hornung et al., 2009) . Since this inflammasome activation led to ASC and caspase-1 activation, these data collectively suggested that ASC and caspase-1 negatively regulated DNA virusinduced type I-IFN production. We then looked for in vivo evidence. Consistent with the above data, Casp1 À/À or Asc À/À mice were resistant to VACV but not VSV infection compared to the wild-type mice ( Figure 1H ), which was associated with lower viral loads in the lungs of Asc À/À and Casp1 À/À mice ( Figure 1I ). Consistently, we detected higher type I-IFN and IL-6 production in the spleens and lungs of Casp1 À/À or Asc À/À mice after VACV infection ( Figure 1J ) and the increased expression of Viperin in organs from deficient mice ( Figure S1F ).
Inflammasome Activation Attenuates DNA VirusTriggered Signaling Because AIM2, ASC, or caspase-1 deficiency resulted in the elevated innate immune responses to DNA virus, we sought to determine the intrinsic correlation between inflammasome activation and type I-IFN induction. First we confirmed that inflammasomes in THP-1 cells were intact, as the processed IL-1b was detected after LPS plus ATP or rotenone treatment (Figure 2A) . Although VACV infection stimulated both IFN and inflammasome activations ( Figures 1D and 2A) , its ability to induce IRF3 phosphorylation and Viperin expression was almost completely lost when inflammasomes were first induced by either LPS plus rotenone ( Figure 2B ), LPS plus ATP ( Figure 2C ), or MALP2 plus ATP ( Figure S2A ). Consistently, VACV triggered type I-IFN production was lost after inflammasome activation (Figures 2D and 2E and S2A) . Similar patterns were found in THP-1 cells infected with HSV-1 ( Figures 2B and 2D and data not shown), but not in those infected with RNA virus SeV (Figure S2B ). These data suggest that enforced inflammasome activation attenuates DNA virus-induced type I-IFN production in human cells. To confirm whether this phenomenon was also true for mouse cells, we used immortalized bone-marrow-derived macrophages (iBMM), which harbor both inflammasome (Figure 2F) and type I-IFN pathways. Inflammasome activation restrained VACV-induced type I-IFN activation, as measured by TBK1 phosphorylation, Viperin, and type I-IFN production ( Figures 2G and S2C ). Inflammasome activation also causes pyroptotic cell death, which would possibly diminish type I-IFN production. However, because the induced inflammasome activation didn't affect RNA virus-induced type I-IFN production, we reasoned that caspase-1-mediated pyroptotic cell death might not be essential role in this process. To confirm this, GSDMDdeficient iBMM cells, which are resistant to caspase-1/11-mediated pyroptosis (Kayagaki et al., 2015; Shi et al., 2015) , were pretreated with LPS plus ATP or rotenone, followed by VACV or SeV infection. We found that DNA virus-triggered type I-IFN production, Viperin or p54 induction was also severely reduced in Gsdmd À/À cells after inflammasome activation (Figures S2D and 2H) . Moreover, cells were also tested with the synthetic triggers of cGAS (dsDNA) and RNA sensors (poly(I:C)). The results were consistent with viral infection in both mouse and human cells, as inflammasome-activated cells showed reduced response to poly(dAdT), but not to poly(I:C) (Figures S2E and S2F) . Together, these data suggest that inflammasome activation attenuates DNA virus-induced type I-IFN production.
Caspase Inhibitors Potentiates DNA Virus-Triggered Signaling To determine whether the pharmacological inhibition of caspase could recapitulate the phenotype caused by genetic deficiencies, we used caspase-1-specific inhibitor VX765, which blocked IL-1b processing ( Figure 3A ) and caspase-1 activation ( Figure 3B ). This inhibitor caused a highly increased expression , and Casp1 À/À mice were infected intranasally (i.n.) with VACV at 3 3 10 6 pfu per mouse or intravenously (i.v.) with VSV at 2 3 10 7 pfu per mouse, and the survival rates of mice were observed and recorded for 2 weeks.
, and Casp1 À/À mice (n = 4) were infected as indicated in (H), and lungs were harvested 2 and 4 days later for viral load measurement.
(J) WT, Asc À/À or Casp1 À/À mice (n = 4) were infected i.v. with VACV at 3 3 10 6 pfu per mouse or VSV at 2 3 10 7 pfu per mouse for 8 hr before cytokines production in organs were measured. *p < 0.05, **p < 0.01, ***p < 0.001, ns p > 0.05. Values are mean ± SEM. Data are representative of three independent experiments. See also Figure S1 .
of Viperin and enhanced IRF3 phosphorylation upon VACV infection ( Figure 3C ). Meanwhile, no change was found for SeV infection. Similarly, Viperin expression and type I-IFN production were increased in mouse peritoneal macrophages ( Figure 3D ) or iBMMs treated with VX765 ( Figure S3A ). Importantly, while preinduced inflammasome activation severely impaired VACV-triggered type I-IFN and Viperin production, the same pre-treatment on Casp1 À/À ( Figure 3E ) or Asc À/À ( Figure S3B ) cells had no effect. Similar results were obtained in CASP1 RNAi cells (Figures S3C and S3D) . These data strongly suggested that inflammasomes-induced innate immune suppression was mediated by caspase-1. Interestingly, when THP-1 cells were treated with z-VAD-fmk, a broad-spectrum inhibitor of caspases, it induced enhanced IRF3 phosphorylation and Viperin expression (Figure 3F ), as well as type I-IFN production ( Figure 3G ) to both RNA and DNA virus infection.
cGAS Is Recruited to and Cleaved by Caspase-1 during Canonical Inflammasome Activation Cytosolic dsDNA triggers cGAS to synthesize cGAMP, which activates STING. Because caspase-1 is essential to suppress DNA virus-induced antiviral immunity, we hypothesized that caspase-1 exerted its effect on either cGAS or STING. We therefore tested protein interaction between caspase-1 and cGAS or STING and found that caspase-1 interacted with cGAS, but not with STING ( Figure 4A ). Critically, this interaction was greatly enhanced by viral infection or inflammasome activation. Similar results were obtained in iBMM cells ( Figure 4B ). To determine which domain of caspase-1 interacts with cGAS, we incubated cell lysates containing Flag-tagged Casp1 or its truncations with purified cGAS protein. We found that cGAS interacted directly with caspase-1 and that this interaction required caspase-1 p20 fragment (Figure 4C) . Interestingly, we repeatedly observed that cGAS protein was diminished after virus infection or inflammasome activation ( Figures 4A, 4B , and S4A). This induced cGAS loss persisted when cellular proteasome and lysosomal pathways were inhibited by MG132 plus Chloroquine ( Figure 4D , MG+Chl), but was reversed when caspase-1 inhibitor was used ( Figure 4D ) or caspase-1 expression was suppressed by shRNA ( Figure 4E ). Because caspase-1 has been shown to cleave various proteins, like Mal and TRIF, we reasoned that caspase-1 might interact with and cleave cGAS.
To prove this hypothesis, we incubated immunoprecipitation (IP) purified human cGAS (h-cGAS) from 293T cells with bacterially purified caspase-1 and analyzed by western blot. A clear band representing the cleaved cGAS, with a molecular weight 15-20 kDa smaller than the control protein was observed ( Figure S4B ). Because purified cGAS was C-terminal Flagtagged, this result indicated that caspase-1 cut cGAS at N terminus. cGAS cleavage did not occur when enzymatic mutant caspase-1 or VX765 was used ( Figure S4C ). On the contrary, STING or IRF3 protein was not cleaved by caspase-1 (Figures S4A and  S4D ). We also used N-terminal 3 3 Flag-and C-terminal GFPtagged h-cGAS to monitor the cleavage of cGAS. Both LPS + ATP ( Figure 4F by caspase-1. Both LPS + ATP and LPS + rotenone caused cGAS disappearance in wild-type, but not Casp1 À/À BMDMs (bone marrow derived macrophages) ( Figure 4H ). The cleaved m-cGAS fragment was detected in cells treated with LPS plus ATP ( Figure 4I ) or infected with VACV or HSV-1 ( Figure S4E ) and was further blocked by the caspase-1 inhibitor. Moreover, IP-purified m-cGAS was cut by caspase-1 in vitro ( Figure 4J ). Figure S5A and manuscript in preparation). cGAS deletion led to complete loss of dsDNA-induced IRF3 phosphorylation ( Figures S5B and S5C ) and type I-IFN production ( Figure S5D ), whereas cGAS reconstitution restored the responses ( Figure S5C ). This cGAS-deficient HeLa cell was then used to scrutinize the actual target(s) on h-cGAS. Because deletion of cGAS N-terminal 160 residues (cGAS-dN) does not affect cGAS activation when overexpressed in 293T cells (Sun et al., 2013) , we first tested whether cGAS-dN would still be cleaved. iBMM cells stably expressing Flag-cGAS-dN-GFP were infected with VACV or SeV, cGAS cleavage was determined by western blot. There was no cleaved bands appeared ( Figure 5A ), indicating that caspase-1 cut h-cGAS within the N terminus. Human cGAS contains six aspartic acids in this area, namely 
E) LPS primed WT and CASP1
RNAi THP-1 cells were treated with ATP for indicated times followed by immunoblotting analysis.
(F and G) iBMM cells stably expressing N-terminal-Flag-tagged and C-terminal-GFP-tagged cGAS (Flag-cGAS-GFP) were pretreated with or without VX765, and then stimulated with LPS plus ATP (F), VACV, SeV, or HSV-1 (G) for the indicated times followed by immunoblotting analysis. (H) WT and Casp1 À/À BMDMs were pretreated with CHX (10 mg/ml) for 1 hr, followed by LPS plus ATP or rotenone for the indicated times followed by immunoblotting analysis. (I) LPS primed iBMM cells were pretreated with CHX (10 mg/ml) for 1 hr, and then left untreated or treated with VX765, followed by ATP stimulation for the indicated times. Cell lysates were analyzed by immunoblotting. L+A, LPS+ATP; VX765, LPS+ATP+VX765. , D 140 , and D 157 , as potential attacking sites for caspase-1 protease. We substituted these aspartic acids by alanine one after another. These cGAS mutants were first shown to activate type I-IFN production when overexpressed (Figure S5E) , and then individually stably-expressed in HeLacGAS À/À cells. When these cells were infected with VACV, we found that each of these cGAS mutant potently activated IRF3 and type I-IFN production ( Figure S5F ). Because there is no intact inflammasome activation pathway in HeLa cells, each cGAS mutant was individually expressed in iBMM cells and followed by cleavage test. It was found that D A cGAS started to show resistance to caspase-1 cleavage. Replacement of all six aspartic acids (D 33-157 A) completely abrogated the cleavage ( Figure 5B) H) substantially inhibited viral infection-induced cGAS cleavage. The combined mutation (DD/AA) completely blocked the cleavage ( Figure 5D ). In agreement with this, cells expressing the mutated cGAS produced more type I-IFNs and ISGs upon DNA virus infection ( Figures 5D and   5E and data not shown). Again, overexpression of these mutants in 293T cells all led to strong type I-IFN activation ( Figure S5H) . Similarly, caspase-1 was also found to target m-cGAS at N terminus ( Figure S5I and data not shown). Deletion of the N-terminal residues (m-cGAS-d6-165) blocked the cleavage. These data collectively demonstrated that caspase-1 targeted h-cGAS at D 140 and D 157 .
Cleavage of cGAS by Caspase-1 Impairs cGAMP Production Next, we tested whether cGAS cleavage would affect cGAMP production. We purified cGAMP from VACV-infected THP-1 cells and found that when inflammasomes were first activated, VACV infection triggered cGAMP production was severely impaired as shown by the reduced IRF3 phosphorylation ( Figure 6A ). Although cGAMP in culture medium induced Digiton-permeabilized THP-1 cells to produce Viperin and type I-IFN (Figures S6A and S6B), this was not affected by inflammasome activation (Figure 6B) . Similar results were found in iBMM cells ( Figure S6C ). These results suggested that inflammasome activation impaired cGAMP production. On the contrary, VACV triggered type I-IFN induction in THP-1 cells was vividly potentiated when caspase-1 was inhibited by VX765 ( Figure S6D ). Consistently, peritoneal AA were infected with VACV for the indicated times followed by immunoblotting analysis (D) and type I-IFN bioassay (E). **p < 0.01, ***p < 0.001. Values are mean ± SEM. Data are representative of three independent experiments. See also Figure S5 . macrophages ( Figure 6C ) and BMDM ( Figure 6D ) from Casp1 À/À mice produced more cGAMP. Altogether, these data showed that active caspase-1 dampened cellular cGAMP production.
cGAS Is Cleaved by Other Pyroptotic Caspases during Non-canonical Inflammasome Activation
In addition, we noticed that the protein level of cGAS was reduced after LPS was delivered into HeLa or iBMM cells ( Figure S7A ), during which process the non-canonical inflammasome caspases, caspase-11 in mouse and caspase-4 and -5 in human, were activated (Shi et al., 2014) . We then tested whether these pyroptotic caspases could also cleave cGAS. Consistent with the cGAS loss in cells treated with LPS, bacterially purified caspase-4, -5, or -11 all cleaved cGAS protein in vitro. Caspase-4 and -11 cleaved cGAS in relatively the same pattern with multiple cleaved bands ( Figure S7B ), indicating the multiple target sites. When overexpressed cGAS was purified and incubated with active caspase-1, -4, or -11, it was confirmed that caspase-4 and -11 cut cGAS differently compared to caspase-1 (Figure S7C) . Again, these caspases only cleaved cGAS, but not STING, TBK1, or IRF3. Caspase-5 also cut cGAS in a different pattern ( Figure S7D ), in which DD/AA mutation had no effect (Figure S7E) . These data collectively suggested that cGAS was cleaved by all inflammatory caspases during either canonical or non-canonical inflammasome activation. during inflammasome activation and that this cleavage led to the loss of cGAS function are inconsistent with the previous results suggesting that h-cGAS N-terminal 160 residues is dispensable for cGAS function (Sun et al., 2013) . To address this discrepancy, we first confirmed that overexpression of either full-length or h-cGAS-dN in 293T cells indeed activated type I-IFN production ( Figure S7F ). However, when h-cGAS-dN was reconstituted in HeLa-cGAS À/À cells, cell response to DNA virus was completely lost ( Figures 7A and 7B ). This result suggested that cGAS N terminus actually plays a critical role under physiological conditions. To examine which region of this area was important, we generated a series of deletions in this region. We found that whereas deletion of the first 120 amino acids of cGAS did not affect its function, further deletion to residue 160 totally abolished cGAS activity ( Figure 7C ), suggesting the importance of residues 120 to 160. Previous work showed that h-cGAS N terminus is able to bind DNA in vitro. In fact, we found that residues 122 to 133 of h-cGAS and residues 119 to 132 of m-cGAS have a cluster of amino acid R and K ( Figure S7G , italic and underlined), positively charged residues important for protein-DNA interaction. This R/K-rich region might thus serve as a DNA binding domain. Deletion analyses revealed that this region was indeed essential for cGAS activation in both human and mouse cells ( Figures 7D and 7E ).
DISCUSSION
Although caspases have been ascribed to a number of functions in addition to their classical ones in apoptosis and inflammation (McIlwain et al., 2015) , their roles in modulating the balance between type I-IFN and inflammasomes have not been thoroughly studied. In this study, we observed that mice lacking AIM2, ASC, or caspase-1 and -11 had enhanced resistance to DNA virus, and that inflammasome negatively regulated antiviral responses by caspasemediated cGAS cleavage. Because so far only intracellular LPS was known to be recognized by caspase-11 (Shi et al., 2014) and DNA virus infection activated inflammasome through AIM2-ASCcaspase-1 pathway (Fernandes-Alnemri et al., 2009; Rathinam et al., 2010) , we concluded that DNA virus-induced hyperresponsiveness in caspase-1and -11 deficient cells or mice was ascribed to the loss of caspase-1. We further demonstrated that caspase-1 directly bound to cGAS through its p20 domain, cleaved h-cGAS at D 140/157 . Similarly, caspase-4 and -5 in human and caspase-11 in mouse were also capable of cGAS cleavage in LPSinduced non-canonical inflammasome activation, though the precise target sites need further investigation. Importantly, the cGAS protein level was severely reduced only after LPS was delivered into cells without caspase inhibitor z-VAD. These results collectively suggested that inflammasome and pyroptosis fine-regulates innate immunity through caspases. Previous work demonstrates that various NLRs negatively regulate type I-IFN induction. NLRC3 is found to interact with both STING and TBK1 to impede STING-TBK1 interaction (Zhang et al., 2014) . NLRP4 promotes TBK1 ubiquitination and degradation (Cui et al., 2010) . Notably, recent work has also provided some evidence showing that inflammasomes regulate gut microbiota in mice (Levy et al., 2015; Man et al., 2016) , and inflammasome defect has been associated with pathologic alterations in gut microbiota, resulting in increased susceptibility to colitis and tumorigenesis (Chen, 2016) . Because mice with different genotypes were kept separately in our experiments, the contribution of gut microbiota to the observed phenotype cannot be ruled out, which needs to be clarified in future studies.
Caspase-dependent apoptosis is unique in its capacity to induce a noninflammatory type of cell death (Tait et al., 2014) .
Recently it has been reported that caspase-3 and -7 are essential for suppressing apoptosis-triggered cGAS-STING activation, although its molecular basis was unknown (Rongvaux et al., 2014; White et al., 2014) . Here we identified a similar regulation in which caspase-1 was critical for limiting cytosolic DNAinduced cGAS-STING activation. These results supported the previous observation that aberrant production of type I-IFN has pathological roles in various autoimmune disorders. Importantly, several pharmacological caspase inhibitors have undergone clinical trials. Our findings indicated that these inhibitors might also cause unwanted immune responses, which might be detrimental to patients in some cases. This kind of side-effects should thus be under close investigation during the clinical trials. Moreover, our study indicated that caspase inhibitors might have the potentials to be used as candidates for antiviral drugs since their abilities to boost innate immune responses.
Evidence also indicates the importance of type I-IFNs in suppressing inflammasome. Type I-IFNs are reported to inhibit NLRP1-and NLRP3-activated inflammasome via STAT1. Type I-IFN-induced IL-10 signals via STAT3 to reduce pro-IL-1a/b production (Guarda et al., 2011; Mayer-Barber et al., 2011) . Numerous studies have shown that type I-IFNs are successfully used in the clinic for the treatment of diseases such as multiple sclerosis (Benveniste and Qin, 2007; Billiau, 2006) . In addition, IFN treatment has also been used to treat Behcet's syndrome and familiar Mediterranean fever, two inflammatory disorders with IL-1 overproduction (Kö tter et al., 2004; Tweezer-Zaks et al., 2008) . These findings reveal a frequent crosstalk between type I-IFNs and inflammasomes, highlighting the importance of the cross-regulation and a potential double-negative feedback loop that regulates the output of DNA-sensing pathways.
Dendritic cells and macrophages deficient in AIM2, ASC, or caspase-1 produce higher amounts of IFN-b in response to DNA transfection, which has been proposed to be due to caspase-1-dependent cell death (Corrales et al., 2016 ). It's conceivable that inflammasome activation-caused pyroptotic cell death would diminish type I-IFN production only if infected cells die before IFNs are produced. However, virus-induced type I-IFN production peaked between 18-24 hr post infection, whereas virus-induced pyroptosis occurred usually around 48 hr after infection (Tan and Chu, 2013; Wu et al., 2013b) , especially when cells were infected at lower viral MOI. Moreover, since the enforced inflammasome activation did not affect RNA virus triggered type I-IFN production, and inflammasome activation caused similarly reduced type I-IFN production in pyroptosisresistant Gsdmd À/À cells, it is unlikely that caspase-1-dependent pyroptotic cell death is essential in this process. In addition, iBMM cells stably expressing cGAS non-cleavable mutants showed normal inflammasome activation to either DNA or RNA virus, but enhanced type I-IFN production to DNA virus, confirming that the cleavage of cGAS accounts for the reduced cytokine production. We found that the N-terminal fragment containing residues 120 to 160 of cGAS is critical for its normal function ex vivo. This finding is somehow surprising since previous work indicated that N terminus of cGAS from amino acids 1 to 160 was dispensable for its function when overexpressed (Sun et al., 2013) , which we believed is most likely caused by overexpression. Moreover, we identified that R/K-rich region in residues 122 to 133 of h-cGAS and 119 to 132 of m-cGAS is required for cGAS activation. We propose that this positively charged region also serves as a DNA binding domain, with the help of the other one located between residues 160 and 212, to form a stable DNA-cGAS complex. In agreement with this, caspase-1 was found to cleave cGAS after this region and inactivate cGAS. Luciferase Reporter Assay 293T cells (1 3 10 5 ) were seeded in 24-well plates and transfected by standard calcium phosphate precipitation method. Reporter assay was performed as previously described (Sun et al., 2009 ).
Type I-IFN Bioassay
Type I-IFN activity was measured as previously described (Jiang et al., 2005) , with reference to a recombinant human or mouse IFN-b (R&D Systems) standard using a 2fTGH cell for human and L929 for mouse stably transfected with an IFN-sensitive (ISRE) luciferase construct.
Caspase-1-Mediated Inflammasome Activation Assay THP-1 cells, iBMMs, or BMDM cells were seeded in 12-well plates overnight before changed with Opti-MEM, and then the cells were primed with LPS (3 mg/ml) or MALP2 (50 ng/ml) for 3 hr followed by various inflammasome ligands stimulation. For NLRP3 inflammasome activation, the cells were treated with ATP (5 mM) for 60 min, rotenone (20 mM) for 6 hr, poly (I:C) (1 mg/ml), or SeV (MOI = 0.1) for the indicated times. For AIM2 inflammasome activation, the cells were transfected with poly (dA:dT) (1 mg/ml) or infected with VACV (MOI = 0.2) for the indicated times. Culture supernatants of THP-1 or iBMM cells treated with indicated stimuli were precipitated by adding an equal volume of methanol and 0.25 volumes of chloroform. The supernatant mixtures were vortexed and then centrifuged for 10 min at 20,000 g. The upper phase was discarded and 500 mL methanol was added to the interphase. This mixture was centrifuged for 10 min at 20,000 g and the protein pellet was dried at 55 C, followed by immunoblotting analysis to detect mature IL-1b p17 in THP-1 cells and mature Casp1 p20 fragment in iBMM cells, respectively.
In Vitro Protease Cleavage Assay Samples contain recombinant caspase protein and its substrate were incubated in caspase assay buffer (100 mM HEPES, 10% (w/v) sucrose, 0.1% (w/v) CHAPS, pH 7.0, 10 mM DTT) at 37 C for 2 hr. Reactions were stopped by boiling in 2x SDS sample buffer and samples were applied to immunoblotting.
In Vitro cGAMP Activity Assay Perfringolysin O (PFO) protein was purified as reported (Gao et al., 2015) . cGAMP from indicated cells was prepared according to the reported protocol (Wu et al., 2013a) . A total of 2 mL cGAMP was mixed with 10 6 THP-1 cells in an 8 mL reaction mixture containing 1.5 ng/ml PFO, and incubated at 30 C for 1.5 hr. Cells were lysed for further immunoblotting analysis.
Digitonin Permeabilization
Cells were treated with cGAMP in 1 mL digitonin solution (50 mM HEPES pH 7.0, 100 mM KCl, 3 mM MgCl 2 , 0.1 mM DTT, 85 mM Sucrose, 0.2% BSA, 1 mM ATP, 0.1 mM GTP, 10 mg/ml digitonin) for 30 min at 37 C. Cells were then incubated in fresh medium for indicated times before type I-IFN bioassay and immunoblotting.
Plaque Assay for Virus Titers in Mouse Organ VACV infectivity was quantified using BSC-1 cell monolayers. Mice infected with VACV (WR strain) were sacrificed at the indicated times. Organs from mice were collected and weighed individually. Organs were disrupted using a tissue homogenizer, frozen, and thawed three times to release the virus. Several 10-fold serial dilutions of the organ supernatant were made, added to individual wells of BSC-1 cell monolayers and incubated in a CO 2 incubator at 37 C for 1-2 days. We aspirated the medium and fixed and stained the cells with 0.1% crystal violet solution for 10 min. Plaques were counted and average counts were multiplied by the dilution factor to determine the viral titer as plaque-forming units per ml. 
Statistical Analysis
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